Utility of Nanosized Microemulsion for Transdermal Delivery of Tolterodine Tartrate: Ex-Vivo Permeation and In-Vivo Pharmacokinetic Studies
- 21 August 2009
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 26 (11) , 2446-2453
Abstract
The aim of this work was to investigate the feasibility of using nanosized microemulsion for transdermal delivery of tolterodine tartrate. The effect of three microemulsions formed by Labrasol: Plurol (3:1), isopropyl myristate and water on the permeation of tolterodine through miniature pig skin was studied in vitro using Franz diffusion cell. For comparison purpose, the effect of different vehicles on the permeation was also studied. Drug pharmacokinetics was studied after transdermal application to human volunteers compared to the commercial oral dosage form using a newly developed LC-MS/MS assay. The vehicle PEG 400:Phosphate buffer pH 7.4 in the ratio of 1:1 significantly enhanced tolterodine permeation across pig skin. The microemulsion system (ME3) containing the highest amount of water (50%) significantly enhanced permeation with Q24 of 0.746 mg.cm−2. In contrast to oral delivery, a sustained activity was observed over a period of 72 h after transdermal application of this microemulsion to human volunteers with significant lower Cmax (1.06 ng/ml), delayed Tmax (3.17 h) and higher MRT value (147.82 h) (p < 0.05). This sustained activity was due to the controlled release of drug into the systemic circulation with expected increase in the patient compliance and prevention of nocturnal enuresis.Keywords
This publication has 30 references indexed in Scilit:
- Control of Transdermal Permeation of Hydrocortisone Acetate from Hydrophilic and Lipophilic FormulationsAAPS PharmSciTech, 2008
- Lipid vesicles for skin delivery of drugs: Reviewing three decades of researchInternational Journal of Pharmaceutics, 2007
- Microemulsions as transdermal drug delivery vehiclesAdvances in Colloid and Interface Science, 2006
- Impact of overactive bladder symptoms on employment, social interactions and emotional well‐being in six European countriesBJU International, 2005
- Clinical Pharmacokinetics of Drugs Used to Treat Urge IncontinenceClinical Pharmacokinetics, 2003
- Multiple Dose Pharmacokinetics of a New Once Daily Extended Release Tolterodine Formulation Versus Immediate Release TolterodineClinical Pharmacokinetics, 2001
- Tolterodine: a new antimuscarinic agent for the treatment of the overactive bladderExpert Opinion on Investigational Drugs, 1999
- Delivery of a hydrophilic solute through the skin from novel microemulsion systemsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1997
- Effects of some hydrophilic permeation enhancers on the absorption of bepridil through excised human skinDrug Development and Industrial Pharmacy, 1992
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991